With your Klinic provider, you will have monthly consultations to optimize your treatment, manage any side effects, and fine-tune your nutrition
Nestl fires back at accusation of adding sugar to infant cereal in Africa Nestl has disputed accusations by the NGO Public Eye that its infant cereals sold in Africa feature added sugar
In October, at the American College of Rheumatology Convergence 2025, interim Phase 1b results for SBT777101, an autologous CAR regulatory T-cell therapy, showed early signs of clinical activity and a favorable safety profile with no dose-limiting toxicities, cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome
Animal studies demonstrate BPC-157 effectiveness across an unusually wide dose range, from 10 nanograms per kilogram to 10 micrograms per kilogram showing comparable efficacy
En la actualidad, las pautas mdicas siguen siendo cautelosas, pero ahora reconocen que los GLP-1 podran ayudar a algunas personas con diabetes tipo 1, especialmente aquellas con resistencia a la insulina o sobrepeso
[4] WebMD